Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
MARLBOROUGH, Mass. and FRANKFURT, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Akoya…
Tilray Medical Launches its First Commercial Grown in Germany Medical Cannabis Products Under its Newly Expanded Cultivation License
NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division…
QCP Trading Receives In-Principle Approval for Major Payment Institution License in Singapore
Key development reinforces QCP Trading's commitment to regulatory excellence in Singapore. SINGAPORE,…
